BioNJ, New Jersey’s life sciences trade association, hosted the Inaugural Health Equity in Clinical Trials MBA Business Plan Case Competition on Saturday, December 3, at Rutgers Business School. BioNJ’s Business Plan Case Competition, which is part of a broader BioNJ strategic initiative of Health Equity in Clinical Trials, was designed to promote the next generation of diverse clinical trial innovators and identify innovative approaches and successful models that can be used nationally to strengthen diversity in clinical trials and expand health equity.
Eight teams, competing for more than $20,000 in prize money, were tasked with developing a business plan defining a new solution, application or technology to help address this important and challenging problem. Teams identified one particular type of health disparity on which to frame their proposed solutions and connected with community-based organizations to better understand the real-world barriers that exist for their chosen populations to engage in clinical trials. The disease areas on which the respective teams focused included Alzheimer’s, heart failure, multiple sclerosis, diabetes type 1 and type 2, colorectal and cervical cancers, and oncology.
The 2022 winning teams:
- First Place: Johns Hopkins University ($10,000) who focused their plan on increasing representation in clinical trials for the treatment of Alzheimer’s Disease through community engagement strategies and the use of digital tools.
- Second Place: Rutgers University ($7,000) who focused their plan on using population health and real-world data analytics to calculate health equity targets specific to clinical trial sites in prostate cancer.
- Third Place: Baylor College of Medicine, Northwestern University & Rice University ($3,500) who focused their plan on increasing Hispanic/Latinx involvement in clinical trials by training community healthcare workers from refugee and immigrant populations.